Tag Archives: Alexion

FDA logo

FDA Approves Drug Produced in Transgenic Chicken

The Food and Drug Administration (FDA) has approved Alexion’s Kanuma (sebelipase alfa), a compound for the treatment of the rare disease lysosomal acid lipase (LAL) deficiency. This is the second time the FDA approves a drug produced¬†in genetically engineered (GE) animals. In 2009, the pharmaceutical company GTC Biotherapeutics obtained FDA approval to commercialize the anticoagulant […]